Education
About Us
Working with TipRanks
Follow Us
NeoGenomics (NEO)
NASDAQ:NEO
Earnings Data
Report Date
Nov 11, 2025TBA (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
0.02Last Year’s EPS
0.05Same Quarter Last Year
Moderate Buy
Based on 11 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook. While the clinical segment showed robust growth and operational achievements, significant challenges in the nonclinical and pharma segments led to a downward revision of the full-year financial guidance. The company is taking steps to address these issues, but the immediate future appears cautious.Company Guidance
Solid Clinical Revenue Growth
Clinical revenue grew by 16% year-over-year, with organic clinical revenue increasing by 13%, driven by a 10% increase in test volumes and a 3% increase in AUP.
NGS Testing Expansion
NGS testing accounted for 32% of total clinical revenue and grew by 23% over the prior year, demonstrating strong market expansion.
Record High Test Volumes
The company reported a record quarter for test volumes, indicating robust demand and operational capacity.
Launch of PanTracer Liquid Biopsy
The PanTracer liquid biopsy is set to launch, expected to positively impact the NGS growth rate later in the year.
Cash Flow and Debt Reduction
Cash flow from operations was a positive $20 million, an improvement of 44% over the prior year, and the company significantly reduced debt by retiring $201 million in convertible notes.
NEO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
NEO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jul 29, 2025 | $6.46 | $5.25 | -18.73% |
Apr 29, 2025 | $9.97 | $6.58 | -34.00% |
Feb 18, 2025 | $14.42 | $12.40 | -14.01% |
Nov 05, 2024 | $14.14 | $14.93 | +5.59% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does NeoGenomics (NEO) report earnings?
NeoGenomics (NEO) is schdueled to report earning on Nov 11, 2025, TBA (Confirmed).
What is NeoGenomics (NEO) earnings time?
NeoGenomics (NEO) earnings time is at Nov 11, 2025, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NEO EPS forecast?
NEO EPS forecast for the fiscal quarter 2025 (Q3) is 0.02.
